GR3001412T3 - 4-benzyl-1-2(h)-phthalazinone derivatives - Google Patents

4-benzyl-1-2(h)-phthalazinone derivatives

Info

Publication number
GR3001412T3
GR3001412T3 GR91400092T GR910400092T GR3001412T3 GR 3001412 T3 GR3001412 T3 GR 3001412T3 GR 91400092 T GR91400092 T GR 91400092T GR 910400092 T GR910400092 T GR 910400092T GR 3001412 T3 GR3001412 T3 GR 3001412T3
Authority
GR
Greece
Prior art keywords
alkylamino
benzyl
alkyl
alkanoyloxy
alkoxy
Prior art date
Application number
GR91400092T
Other languages
English (en)
Inventor
Juergen Dr Engel
Gerhard Dr Scheffler
Original Assignee
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag
Publication of GR3001412T3 publication Critical patent/GR3001412T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GR91400092T 1985-11-11 1991-01-31 4-benzyl-1-2(h)-phthalazinone derivatives GR3001412T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3539873 1985-11-11

Publications (1)

Publication Number Publication Date
GR3001412T3 true GR3001412T3 (en) 1992-09-25

Family

ID=6285623

Family Applications (1)

Application Number Title Priority Date Filing Date
GR91400092T GR3001412T3 (en) 1985-11-11 1991-01-31 4-benzyl-1-2(h)-phthalazinone derivatives

Country Status (20)

Country Link
US (1) US4841047A (el)
EP (1) EP0222191B1 (el)
JP (1) JPH0780871B2 (el)
CN (1) CN86107627A (el)
AT (1) ATE60598T1 (el)
AU (1) AU593593B2 (el)
CA (1) CA1295613C (el)
DD (1) DD263058A5 (el)
DE (1) DE3677322D1 (el)
DK (1) DK172076B1 (el)
ES (1) ES2031813T3 (el)
FI (1) FI88504C (el)
GR (1) GR3001412T3 (el)
HU (1) HU196793B (el)
IE (1) IE59056B1 (el)
IL (1) IL80560A0 (el)
NO (1) NO864474L (el)
PT (1) PT83713B (el)
SU (1) SU1454251A3 (el)
ZA (1) ZA868531B (el)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE64051B1 (en) * 1987-11-13 1995-06-28 Asta Medica Ag Azelastine embonate process for its preparation and pharmaceutical preparations which contain azelastine embonate as active substance
EP0322153A3 (en) * 1987-12-21 1990-08-16 Pfizer Inc. Heterocyclic oxophtalazinyl acetic acids
FR2643373B1 (fr) * 1989-01-10 1993-12-31 Adir Cie Nouveaux derives des bisarylalcenes, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
ATE107643T1 (de) * 1989-05-05 1994-07-15 Asta Medica Ag Salze des azelastins mit verbesserter löslichkeit.
JPH04198180A (ja) * 1990-11-28 1992-07-17 Eezai Kagaku Kk ベンジルフタラゾン誘導体の製造方法
DE4207234A1 (de) * 1992-03-07 1993-09-09 Asta Medica Ag Neue aminocarbonsaeure-derivate mit antiallergischer/antiasthmatischer wirkung und verfahren zu deren herstellung
EP0561166A1 (de) * 1992-03-17 1993-09-22 ASTA Medica Aktiengesellschaft Dosieraerosole enthaltend den Wirkstoff D-18024 und verwandte Strukturen
CZ199593A3 (en) * 1992-10-02 1994-04-13 Asta Medica Ag Phthalazinone derivatives exhibiting anti-arrhythmic and analgesic activity and eliminating resistance to a plurality of medicaments (mdr)
US7151102B2 (en) * 2000-10-30 2006-12-19 Kudos Pharmaceuticals Limited Phthalazinone derivatives
EP1501822B1 (en) * 2002-04-30 2010-12-15 Kudos Pharmaceuticals Limited Phthalazinone derivatives
US7449464B2 (en) * 2003-03-12 2008-11-11 Kudos Pharmaceuticals Limited Phthalazinone derivatives
GB0305681D0 (en) 2003-03-12 2003-04-16 Kudos Pharm Ltd Phthalazinone derivatives
GB0419072D0 (en) 2004-08-26 2004-09-29 Kudos Pharm Ltd Phthalazinone derivatives
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
NZ555501A (en) 2004-11-24 2010-01-29 Medpointe Healthcare Inc Compositions comprising azelastine and methods of use thereof
GB0428111D0 (en) * 2004-12-22 2005-01-26 Kudos Pharm Ltd Pthalazinone derivatives
GB0521373D0 (en) 2005-10-20 2005-11-30 Kudos Pharm Ltd Pthalazinone derivatives
US20090105225A1 (en) * 2006-04-20 2009-04-23 Glaxo Group Limited 2-Substituted 4-Benzylphthalazinone Derivatives as Histamine H1 and H3 Antagonists
WO2007144639A1 (en) * 2006-06-15 2007-12-21 Kudos Pharmaceuticals Limited 2 -oxybenzamide derivatives as parp inhibitors
CN101484436A (zh) * 2006-06-15 2009-07-15 库多斯药物有限公司 作为parp抑制剂的2-氧基杂芳基酰胺衍生物
EP2035380A2 (en) * 2006-06-15 2009-03-18 Kudos Pharmaceuticals Limited Parp inhibitors
TWI404716B (zh) * 2006-10-17 2013-08-11 Kudos Pharm Ltd 酞嗪酮（ｐｈｔｈａｌａｚｉｎｏｎｅ）衍生物
TW200831493A (en) * 2006-12-20 2008-08-01 Glaxo Group Ltd Compounds
US20080280910A1 (en) * 2007-03-22 2008-11-13 Keith Allan Menear Phthalazinone derivatives
TW200900396A (en) * 2007-04-10 2009-01-01 Kudos Pharm Ltd Phthalazinone derivatives
US20090023727A1 (en) * 2007-07-05 2009-01-22 Muhammad Hashim Javaid Phthalazinone derivatives
JP2010539149A (ja) 2007-09-14 2010-12-16 アストラゼネカ アクチボラグ フタラジノン誘導体
US20100216799A1 (en) * 2007-10-11 2010-08-26 Glaxo Group Limited Phthalazine and pyrido[3,4-d]pyridazine compounds as h1 receptor antagonists
AU2008313467B2 (en) * 2007-10-17 2013-08-29 Kudos Pharmaceuticals Limited 4- [3- (4-cyclopropanecarbonyl-piperazine-1-carbonyl) -4 -fluoro-benzyl] -2H-phthalazin-1-one
UY31603A1 (es) 2008-01-23 2009-08-31 Derivados de ftalazinona
JP5524220B2 (ja) 2008-10-07 2014-06-18 アストラゼネカ・ユーケイ・リミテッド 医薬配合物５１４
UY32790A (es) * 2009-07-15 2011-02-28 Astrazeneca Ab Compuesto de ftalazinona
CN113956239A (zh) * 2021-10-28 2022-01-21 昆明源瑞制药有限公司 一种盐酸氮卓斯汀及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3017411A (en) * 1962-01-16 New substituted phthalazones and proc-
DE2114884A1 (de) * 1971-03-27 1972-10-12 Cassella Farbwerke Mainkur Ag, 6000 Frankfurt Basisch substituierte Derivate des 1(2H)-Phthalazinons
US3813384A (en) * 1972-01-17 1974-05-28 Asta Werke Ag Chem Fab Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof
DE3530793A1 (de) * 1984-09-14 1986-03-27 Asta-Werke Ag Chemische Fabrik, 4800 Bielefeld Substituierte benzylphthalazinon-derivate
ATE49205T1 (de) * 1984-09-14 1990-01-15 Asta Pharma Ag Substituierte benzylphthalazinon-derivate.

Also Published As

Publication number Publication date
SU1454251A3 (ru) 1989-01-23
FI864555A0 (fi) 1986-11-10
NO864474D0 (no) 1986-11-10
CA1295613C (en) 1992-02-11
FI88504B (fi) 1993-02-15
PT83713A (de) 1986-12-01
JPS62114987A (ja) 1987-05-26
IE862960L (en) 1987-05-11
PT83713B (pt) 1989-06-30
EP0222191A1 (de) 1987-05-20
DD263058A5 (de) 1988-12-21
IE59056B1 (en) 1993-12-15
DK536486D0 (da) 1986-11-10
ATE60598T1 (de) 1991-02-15
CN86107627A (zh) 1987-07-15
FI88504C (fi) 1993-05-25
HU196793B (en) 1989-01-30
FI864555A (fi) 1987-05-12
EP0222191B1 (de) 1991-01-30
ES2031813T3 (es) 1993-01-01
DK536486A (da) 1987-05-12
AU6498286A (en) 1987-05-14
US4841047A (en) 1989-06-20
NO864474L (no) 1987-05-12
IL80560A0 (en) 1987-02-27
AU593593B2 (en) 1990-02-15
JPH0780871B2 (ja) 1995-08-30
HUT42084A (en) 1987-06-29
DE3677322D1 (de) 1991-03-07
DK172076B1 (da) 1997-10-13
ZA868531B (en) 1987-07-29

Similar Documents

Publication Publication Date Title
GR3001412T3 (en) 4-benzyl-1-2(h)-phthalazinone derivatives
ATE239477T1 (de) Chinolone und deren therapeutische verwendung
PL319104A1 (en) 2,3-dihydro-1-(2,2,2-trifluoroethly0)-2-oxo-5-phenyl-1h-1,4-benzodiazepinmes
TW328954B (en) Quinoxalines, a process for their preparation, and their use
AU543677B2 (en) 5,10-dihyro-11h-dibenzo(b,e)(1,4)diazepine-11-ones
ES2104174T3 (es) Derivados de bencilamino, bencilamido y bencilimido ciclicos utilizados como agentes antipsicoticos.
ATE27453T1 (de) 6-aryl-4,5-dihydro-3(2h)-pyridazinone,ihre herstellung und verwendung.
DK571989D0 (da) Hydroxy-1,2,3,4-tetrahydroaminoacridiner, deres fremstilling og anvendelse
NO961719L (no) 3-aryl-4-alkyl og 4,5-dialkyl-4H-1,2,4-triazoler som er anvendbare som hukommelsesforsterkere
DK0458331T3 (da) Pyrido/3,4-b/ pyrrolo/ 1,2-e/ /1,4,5/oxadiazepiner og beslægtede analoge, fremgangsmåder til deres fremstilling og deres an
ZA828877B (en) Therapeutically useful 3,7a-diazacyclohepta(j,k)fluorene derivatives
ES2079926T3 (es) Procedimiento para la obtencion de 4-dialcoximetilpirazoles.
EP0700395A1 (en) INDOLA DERIVATIVES AS INHIBITORS OF STEROIDAL 5-g (a) -REDUCTASE
ES8703422A1 (es) Un metodo para preparar derivados de 1-amino-2-benzoilpirrol
ES2018977A6 (es) Procedimiento de preparacion de n-ciclopropil-4-fluoroanilinas.
TW326448B (en) Substituted quinoline herbicide intermediates and process
JO1825B1 (en) Therapeutic agents